Assistant Professor, Pathology and Laboratory Medicine, University of Kentucky College of Medicine
Pathology
Dr. Craig M. Horbinski, MD
|
|
Give Review
Doctor Craig M. Horbinski, MD is an expert in the field of Pathology. He went to medical school at University at Buffalo, School of Medicine and Biomedical Sciences. Dr. Craig M. Horbinski has written publications. He has 56 publications published with PubMed. The lastest paper is: 'Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.' Craig Horbinski accepts Medicare payments and is listed with Medicare.gov.
Publications
- Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
- Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer.
- Mitochondrial control by DRP1 in brain tumor initiating cells.
- The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
- Foreign Body Granuloma Following Orbital Reconstruction with Porous Polyethylene.
- Epidemiologic and Molecular Prognostic Review of Glioblastoma.
- PARP-1 Regulates Epithelial-Mesenchymal-Transition (EMT) in Prostate Tumorigenesis.
- ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.
- Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.
- Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.
- Sudemycin E influences alternative splicing and changes chromatin modifications.
- Cofilin Drives Cell Invasive and Metastatic Responses to TGF-β in Prostate Cancer.
- Autophagy and oxidative stress in gliomas with IDH1 mutations.
- 1p/19q testing has no significance in the workup of glioblastomas.
- What do we know about IDH1/2 mutations so far, and how do we use it?
- How Molecular Testing Can Help (and Hurt) in the Workup of Gliomas.
- PDGFRA Amplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma.
- To BRAF or not to BRAF: is that even a question anymore?
- Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4.
- Something old and something new about molecular diagnostics in gliomas.
- Lgr5 Marks Post-Mitotic, Lineage Restricted Cerebellar Granule Neurons during Postnatal Development.
- The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
- Live free or die: tales of homeless (cells) in cancer.
- A 10-year old girl with neck pain.
- Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies.
- YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
- Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.
- Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.
- Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas.
- Comparison of telepathology systems in neuropathological intraoperative consultations.
- Application of telepathology for neuropathologic intraoperative consultations.
- Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern.
- Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplication.
- Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth fa...
- Chordoid glioma: a case report and molecular characterization of five cases.
- The equivocally amplified HER2 FISH result on breast core biopsy: indications for further sampling do affect patient management.
- Telepathology for intraoperative neuropathologic consultations at an academic medical center: a 5-year report.
- 6-Hydroxydopamine induces mitochondrial ERK activation.
- Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.
- Kinase signaling cascades in the mitochondrion: a matter of life or death.
- Proteasome inhibitors suppress formation of polyglutamine-induced nuclear inclusions in cultured postmitotic neurons.
- DMT1: a mammalian transporter for multiple metals.
- Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation.
- Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway.
- Cerebrospinal fluid contains biologically active bone morphogenetic protein-7.
- Dendritic growth induced by BMP-7 requires Smad1 and proteasome activity.
- Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina.
- Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells.
- The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss ...
- EGFR expression stratifies oligodendroglioma behavior.
- Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.
- Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.
- Low-grade recurrence of a congenital high-grade supratentorial tumor with astrocytic features in the absence of adjuvant therapy.
- Practical molecular diagnostics in neuropathology: making a tough job a little easier.
- Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer.
Schools
State University of New York At Buffalo
Doctors Specialties
- Neuropathology
- Pathology
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
University of Pittsburgh Medical Center-Mercy Hospital -
University at Buffalo, School of Medicine and Biomedical Sciences
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730345026 |
| Last Name Of The Provider | HORBINSKI |
| First Name Of The Provider | CRAIG |
| View All |
Similar Doctors
|
|
Dr. Julie A. Ribes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. Tanous Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daron G. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana L. Richards, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janna H. Neltner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James C. McManis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dianne Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace D. Dukes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhan Ye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Bodnar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter T. Nelson, MD
This Doctor is OpenDoctor Recommended.
|